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To discuss the feasibility of low-dose whole-pancreas imaging utilizing 640-slice dynamic volume CT.80 patients
(40 cases of normal pancreas and 40 patients supposed of having pancreatic carcinoma or focal pancreatic
space-occupying lesions were mainly refered) referred for CT pancreas perfusion were enrolled in the study. 80 patients
randomly assigned to 3 groups: Group ① (whole sequence). Group ② (odd number sequence). Group ③ (even
number group)(Compared to ①, the scanning times and effective radiate dose of ② and ③ decreased about 50%
respectively). The head, body, tail of each normal pancreas without any pancreatic disease, lesion and lesion-surrounding
areas of each pancreatic cancer were selected as ROI, and tissue peak, blood flow are measured.According to pathology
and clinical materials, 27 patients were diagnosed as pancreatic cancer; 40 patients were diagnosed as normal pancreas.
The tissue peak and blood flow of the head, body, tail of normal pancreas without any pancreatic disease are 109.63 ±
16.60 and 131.90 ± 41.61, 104.38 ± 19.39 and 127.78 ± 42.52, 104.55 ± 15. 44 and 123.50 ± 33.44 respectively. The tissue
peak and blood flow of pancreatic cancer is 59.59 ± 18.20 and 60.00 ± 15.36. For and between each group, there is no
significant statistical difference for the tissue peak and blood flow of normal areas of the head, body, tail of normal
pancreas. There is statistical difference for the tissue peak and blood flow of lesion and lesion-surrounding areas of
pancreatic cancer in each group. However, there is no statistical difference for the tissue peak and blood flow of normal
and diseasing areas between 3 groups.Low-dose whole-pancreas perfusion with 640-slice dynamic volume CT is feasible.
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With the development of wide coverage CT, CT-perfusion
us increasing popular, and applied to abdominal organs,
including liver, kidney, pancreas (Pandharipande et al.
2005; Van Beers et al. 2001; Daghini et al. 2007; Ma et al.
2008). For technical reasons, such as the width-restrained
detector, organ condition, and high-dose which is still the
primary consideration, the application of CT-perfusion is
clinically limited (Schindera et al. 2008; Nakayama et al.
2005). However, a 640-slice CT (Aquilion One: Toshiba
Medical Systems) makes rapid scanning, low-dose and
whole-organ perfusion possible. In this study, we evalu-
ated the feasibility of low-dose scanning through compar-
ing changes of tissue peak and blood flow of normal
tissues, lesions and its surrounding areas of each pancreas.* Correspondence: renke815@sina.com
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Subject
From March of 2013 to December of 2014, 40 patients
chosen from outpatients and inpatients and clinically
supposed to have pancreatic cancer or other pancreatic
occupying disease were collected to undertake
Toshiba640- slice dynamic volume CT for pancreatic
perfusion. Half of them are males and half of them are
females. Their age varies from 17 to 72 years old, and
the average age is 54 years old. All patients received
therapy in hospital post-scanning. They all had been
proved to have no renal dysfunction and allergy to con-
trast material. All patients and their next of kin provided
written informed medical consent to the study. The
study was reviewed and approved by the ethics commit-
tee before the study began. Meanwhile, collected 40
cases of normal pancreas cases without any pancreatic
disease to control group, 25 males and 15 females, Their
age varies from 20 to 67 years old, and the average age is
45 years old.pen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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For successful operation, we elaborated the perfusion in-
dications, adverse reactions, operation procedures and
gastrointestinal preparation methods to patients before
scanning. The contrast agent (Iohexol 320 mg/ml) is
injected via right medial cubital vein. Toshiba 640- slice
dynamic volume CT is selected as the scanning appar-
atus. The scanning parameters: tube voltage 100 kV, tube
current 50 mA, slice thickness 0.5 mm, scanning range
160 mm, pitch 87, matrix 512 × 512, volume scan image
reconstruction with adaptive iterative dose reduction 3D
(AIDR 3D) algorithm. For each patient,40 ml Iohexol
and 40 ml physiological saline are injected with the flow-
ing rate of5.0 ml/s. The contrast agent injection and
scanning began at the same time to ensure acquisition of
two groups of imaging (equivalently to plain scan ) be-
fore the enhancement of aorta. The whole perfusion
took 36 s, composing of 12 sequences. 12 sequences: 2,
10, 12, 14, 16, 19, 21, 23, 26, 29, 31, 36 s.
Imaging diagnosis
40 patients supposed to have pancreatic cancer or other
pancreatic occupying disease performed pancreatic CT-
perfusion. According to radiologic reports, there were 28
cases of pancreatic cancer, 2 cases of pancreatitis, 1 case
of retroperitoneal lymphoma with tail pancreatic inva-
sion, 1 case of solid-pseudopapillary tumor of pancreas,
2 cases of islet cell tumor, 1 case of duodenal cancer,
and 5 normal cases.
Image processing and analysis
Images were then transferred to a PC using the newly in-
troduced enhanced CT DICOM protocol. Post-processingFigure 1 Pathology results. a represents the pathology results images of pstarted on our inhouse developed software(H.M.) with
images registration as the first step, focusing on the
pancreas in order to correct for motion and breathing
differences in all three planes. Each patient had 12 raw
image sequences, and we defined sequences 1–12 as
Group ① (whole sequence); sequences composed of 1st,
3rd, 5th, 7th, 9th, and 11th as Group ② (odd number
sequence); and sequences composed of 2nd, 4th, 6th,
8th, 10th, and 12th as Group ③ (even number se-
quence). Then, we analyzed all sequences by maximum
slope method (Sorensen et al. 1999). Abdominal aorta,
normal areas of the without any pancreatic disease
head, body, tail and lesion, lesion-surrounding areas of
with pancreatic disease were selected as ROI, and the
time-density curve of each ROI was calculated. ROI
should be placed in the middle of normal pancreas or in
strengthening area with lesion, avoiding the edging area
as far as possible or the necrosis area lesion. The range
of each ROI was about 1 ~ 3 mm2. The time-intensity
curve of abdominal aorta, normal pancreatic areas was
taken as reference standard to generate pseudo color,
and then the responding blood flow is calculated.
Herein, head pancreatic was generally chosen to substi-
tute normal pancreatic areas. Once space-occupying le-
sion was found in head pancreatic, the head pancreatic
adjacent areas or body pancreatic was selected.
Radiation dose
For each patient, the total radiation dose one received
was defined as Effective Radiation dose (mSv). Radiation
dose = DLP · k, herein, DLP (mGy•cm) was dose-length.
For abdominal scan, k was about 0.015 (CEC 1999). The
post-processing and reading of images were finished byancreatic cancer.
Figure 2 ROI, time density curve and blood flow image of normal pancreas. A1(B1,C1) shows the ROI of normal pancreas without any
pancreatic disease in whole sequence (odd number sequence,even number group). A2 (B2,C2) represents the corresponding time density curve;
A3 (B3,C3) represents the blood flow image.
Figure 3 ROI, time density curve and blood flow image of pancreatic cancer (and the area adjacent to pancreatic cancer). E1, G1, L1 (F1, H1, M1)
shows the ROI of pancreatic cancer (and the area adjacent to pancreatic cancer) in whole sequence,odd number sequence,even number group.
E2, G2, L2 (F2, H2, M2) represents the corresponding time density curve; E3, G3, L3 (F3, H3, M3) represents the blood flow image.
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Table 1 The statistical analysis of tissue peak, blood floe of norma areas of 40 cases of pancreatic without any
pancreatic disease head, body and tail in 3 groups
ROI Perfusion parameter (x  s) Group ① Group ② Group ③ F value P value
Head pancreatic Tissue peak 109.63 ± 16.60 104.58 ± 14.58 103.45 ± 14.60 1.850 0.162
BF 131.90 ± 41.61 127.48 ± 68.54 139.98 ± 86.56 0.346 0.708
Body pancreatic Tissue peak 104.38 ± 19.39 100.33 ± 17.96 98.38 ± 16.33 1.165 0.316
BF 127.78 ± 42.52 121.48 ± 67.38 130.48 ± 76.98 0.209 0.812
Tail pancreatic Tissue peak 104.55 ± 15.44 101.43 ± 17.17 100.08 ± 14.35 0.855 0.428
BF 123.50 ± 33.44 121.48 ± 77.77 131.88 ± 88.32 0.244 0.784
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ment of radiology.
Statistical analysis
Data were statistically analyzed by SPSS13.0. Quantita-
tive Data were expressed as mean ± S.D. Differences
were considered significant at a level of α = 0.05.
Results
40 patients by surgical pathologically proven and clinical
diagnosis. There were 27 pancreatic cancer patients, of
which, 16 cases ( 10 cases located in head, and 6 cases in
body of pancreas ) were pathologically proven (Figure 1),
11cases (7 cases located in head, 3 cases in body and 1
case in tail of pancreas ) proven by follow-up and clinical
behaviors, and 5 cases accompanying with liver metastasis.
1 case of solid-pseudopapillary tumor, 1 case of duodenal
cancer and 2 cases of islet cell tumor were pathologically
proven. The remaining 4 cases did not perform surgery,
and were diagnosed as cystoadenoma, cystic tumor, non-
functional islet cell tumor or solid-pseudopapillary tumor
according to clinical behaviors.
Compare the tissue peak, blood flow of the head, body,
tail areas of normal pancreas without any pancreatic dis-
ease, lesion and lesion-surrounding areas of pancreatic
cancer in 3 groups and inner 3 groups (Figures 2 and 3
and Tables 1, 2, 3 and 4).
In our study, each patient got 12 scanning sequences,
i.e. 12 data packages. Table 1 shows that the tissue peak
and blood flow of head, body, tail areas of normal pan-
creas without any pancreatic disease are 109.63 ± 16.60
and 131.90 ± 41.61, 104.38 ± 19.39 and 127.78 ± 42.52,Table 2 The statistical analysis of tissue peak, blood flow of n
pancreatic disease head, body and tail inner 3 groups
Group Perfusion parameter (x  s) Head pancreatic
Group ① Tissue peak 109.63 ± 16.60
BF 131.90 ± 41.61
Group ② Tissue peak 104.58 ± 14.58
BF 127.48 ± 68.54
Group ③ Tissue peak 103.45 ± 14.60
BF 139.98 ± 86.56104.55 ± 15. 44 and 123.50 ± 33.44 in Group ①, and
there is no statistic significance with the values from
Group ②, Group ③. Table 2 compares the tissue peak,
blood flow of the head, body, tail areas of normal pan-
creas without any pancreatic disease from Group ①,
Group ②, Group ③,There is no statistic significance be-
tween the three areas no matter which scan aequence
we apply. Table 3 shows the tissue peak and blood flow
of lesion and lesion-surrounding areas of pancreatic can-
cer is 59.59 ± 18.20 and 60.00 ± 15.36, 101.11 ± 12.19 and
108.19 ± 21.77 in Group ①, and there is no statistic sig-
nificance with the values from Group ②, Group ③.
Table 4 delineates there are statistical differences of tis-
sue peak, blood flow between lesion and lesion-
surrounding areas of pancreatic cancer in Group ①,
Group ②, Group ③, the tissue peak and blood flow of
lesion areas of pancreatic cancer is significantly lower
than lesion-surrounding areas.
Discussion
In 1991, Miles who was one of the peers to define the
concept of CT-perfusion, undertook abdominal organ’s
CT perfusion, and established artificial picture (Miles
et al. 1991). In 1995, Miles initiated the application of
CT perfusion method in pancreatic diseases and mea-
sured the perfusion parameters (blood flow, blood vol-
ume, time to peak, permeability picture, and Patlak
blood volume) of normal pancreatic tissue, different le-
sions (Miles et al. 1995). In recent years, CT perfusion
was clinically valuable in diagnosis, differential diagnosis
of pancreatic tumors and the prognosis of transplanted
pancreas. However, the high radiation dose of multi-sliceormal areas of 40 cases of pancreatic without any
Body pancreatic Tail pancreatic F value P value
104.38 ± 19.39 104.55 ± 15.44 1.199 0.305
127.78 ± 42.52 123.50 ± 33.44 0.455 0.636
100.33 ± 17.96 101.43 ± 17.17 0.703 0.497
121.48 ± 67.38 121.48 ± 77.77 0.094 0.910
98.38 ± 16.33 100.08 ± 14.35 1.167 0.315
130.48 ± 76.98 131.88 ± 88.32 0.149 0.862
Table 3 The statistical analysis of tissue peak, blood flow of 27 cases of pancreatic cancer and cancer-surrounding
areas in 3 groups
ROI Perfusion parameter (x  s) Group ① Group ② Group ③ F value P value
Pancreatic cancer Tissue peak 59.59 ± 18.20 61.93 ± 19.73 59.04 ± 18.49 0.179 0.836
BF 60.00 ± 15.36 56.22 ± 20.56 60.81 ± 26.85 0.353 0.704
Cancer-surrounding areas Tissue peak 101.11 ± 12.19 98.33 ± 12.35 99.00 ± 12.71 0.368 0.693
BF 108.19 ± 21.77 103.67 ± 21.75 113.07 ± 30.08 0.968 0.384
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(Valentin 2007; HaU 2002; Hart et al. 2009; ICRP 2008;
Li et al. 2014). With advancing of CT imaging technology,
application of CT perfusion in pancreatic tumors is in-
creasing popular. Our research aims at the feasibility study
of low-dose whole-pancreas CT perfusion.
Each patient got 12 scanning sequences, i.e. 12 data
packages. From Table 2, we conclude that different normal
pancreatic areas, there is no discrimination in its tissue
peak and blood flow. The data from Table 4 suggests the
pancreatic cancer,s tissue peak and blood flow is signifi-
cantly different from its lesion-surrounding areas of pan-
creatic cancer, and the former is lower than the later.
Pancreas is an organ with rich blood supply, and its arter-
ial blood supply comes from superior pancreaticoduodenal
artery, inferior pancreaticoduodenal artery, dorsal pancre-
atic artery, transverse pancreatic artery and branches of
splenic artery. The blood supply of head pancreatic mainly
comes from superior and inferior pancreaticoduodenal ar-
tery, and their branches converge into anterior, posterior
pancreaticoduodenal arcade. the splenic artery mainly sup-
plies the body and tail of the pancreas (Takeda et al. 2005).
Although there is discrimination of arterial blood supply,
the difference of blood flow and tissue peak of different
pancreatic areas is not obvious (Xu et al. 2009; Xie et al.
2013). As shown in Tables 2 and 4 , our results are in
agreement with most previous reports (Xu et al. 2009.
However, someone (Tsushina and Kusano 1998) reports
the arterial blood supply in head pancreatic is lower than
that of tail pancreatic. It is known to all that pancreatic
cancer is in shortage of arterial blood supply. As shown in
Table 4, the tissue peak and blood flow of pancreatic can-
cer areas is 59.59 ± 18.20 and 60.00 ± 15.36, lower thanTable 4 The statistical analysis of tissue peak, blood flow of 2
areas inner 3 groups
Groups Perfusion parameter (x  s) Pancreatic cancer
Group ① Tissue peak 59.59 ± 18.20
BF 60.00 ± 15.36
Group ② Tissue peak 61.93 ± 19.73
BF 56.22 ± 20.56
Group ③ Tissue peak 59.04 ± 18.49
BF 60.81 ± 26.85cancer-surrounding areas, and it’s in accordance with that
pancreatic cancer has low blood supply. The lower tissue
peak and blood flow results from the decreased permeabil-
ity, low blood flow of pancreatic cancer, and increased
interstitial tissues in tumor (Ma et al. 2008; McNulty et al.
2001; Miles et al. 2000; Ikeda et al. 1999). One defect of
CT perfusion is its high radiation dose. Therefore, we
propose to reduce tube current and scanning sequences
(Ma et al. 2008; Xu et al. 2009; Xie et al. 2013; Tsushina
and Kusano 1998; McNulty et al. 2001; Miles et al. 2000;
Ikeda et al. 1999; Hashimoto et al. 2006). The CT images
qualification was diagnostic satisfying with tube current
being 50 mA. In previous reports (Xu et al. 2009; Xie et al.
2013 Tsushina and Kusano 1998; McNulty et al. 2001;
Miles et al. 2000; Ikeda et al. 1999; Hashimoto et al. 2006),
different tube currents were also applied, but they were
most higher than 100 mA. However, Kadel S et al. (2009).
used 45 mA tube current (100-kV tube voltage) on 320-
slice helical CT and the total radiation exposure was 14.7
mSv. When only odd number sequence or even number
sequence was performed, the radiation dose becomes half
of that when Group ① was performed. Tables 1 and 3
shows that, the effective radiation dose for Group ①
method is 13.51 ± 0.52 mSv, Group ② or Group ③ is
6.75 ± 0.27 mSv. In the each group, there is no difference
in tissue peak and blood flow, though scan sequences, ra-
diation dose decreased in group ②,③ compared with
group ①. This shows that scanning method ② and ③
have no influence on the final results; thus, semi-dose
( low-dose ) scanning method is acceptable.
The narrow detector, respiratory motion from patients,
long scanning time limited the application of CT perfu-
sion in the past. We adapt dynamic volume scan mode.7 cases of pancreatic cancer and cancer-surrounding
Cancer-surrounding areas T value p value
101.11 ± 12.19 −11.141 0.000
108.19 ± 21.77 −9.992 0.000
98.33 ± 12.35 −9.731 0.000
103.67 ± 21.75 −12.084 0.000
99.00 ± 12.71 −10.586 0.000
113.07 ± 30.08 −12.259 0.000
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single axial scan with a range of 160 mm. The large scan
range covers not only pancreas but also the organs adja-
cent. Therefore, Toshiba 640- slice dynamic volume CT
can shorten the scanning time and decrease the radi-
ation dose. The CT perfusion analysis is not based on
the high quality images from each volume data but on
the intensity disparities emerging from different image
groups. So the rapid and halve-dose scanning method
does not impair image diagnosis (Kandel et al. 2009).
At present, the diagnosis of pancreatic cancer mainly
depends on qualitative results from the under enhanced
lesions observed in contrast enhanced CT scanning.
However, a majority of pancreatic diseases are insuffi-
cient in blood supply, except for neuroendocrine tumors.
Thus, for the lesions with insufficient blood supply, fur-
ther quantitative diagnosis is needed. In light of the fact,
a better diagnostic method is wanted. According to
curve trend, tissue peak and blood flow, in descending
order, we can not define a concrete critical value
responding to different pancreatic diseases. One defi-
ciency of this study is the small number of cases, which
makes the CT perfusion’s differential diagnosis capacity
ambiguously. Even though, the perfusion images ac-
quired in this study composed of time-intensity curve,
blood flow, render more information than previous pan-
creas perfusion (D’Onofrio et al. 2013).
Conclusion
In conclusion, by using the method of low-dose whole-
pancreas perfusion, scan sequences and radiation dose
are halved, and the diagnosis capacity is not impaired.
The curve slope, tissue peak, blood flow is approxi-
mately equivalent to previous reports. Thus, low-dose
whole-pancreas perfusion is desirable to be an important
method to diagnose pancreatic diseases, especially evalu-
ating effects of early treatment for malignant tumors.
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